Published date: 4 March 2021

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 14 January 2020, 12pm

Contract summary

Industry

  • Medical equipments - 33100000

  • Medical consumables - 33140000

  • Diagnostic kits - 33141625

    • Biomedical equipment - 38434540

    • Repair and maintenance services of medical equipment - 50421000

Location of contract

Any region

Value of contract

£502,000

Procurement reference

tender_198621/930801

Published date

4 March 2021

Closing date

14 January 2020

Closing time

12pm

Contract start date

12 February 2021

Contract end date

11 February 2025

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas:
- Solid organ transplantation and clinical advice for donor selection
- Haematopoietic stem cell transplantation and clinical advice for donor selection
- Blood transfusion and transfusion reactions (SHOT)
- Platelet refractoriness and provision of HLA/ HPA selected components
- Platelet immunology
- Granulocyte immunology
- Immunogenetics including diagnostic testing and pharmacogenetics
- Haematopoietic stem cell donor registry typing

NHSBT require HLA typing systems that can produce a result in less than two hours. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.
We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.

For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement.

The Framework Agreement was awarded for 4 years and divided into lots as follows:

Lot 1 - New HLA (Rapid) typing equipment - awarded to VH Bio
Lot 2 - Kits for HLA (Rapid) typing systems - awarded to VH Bio Ltd and Alpha Biotech Ltd

Award information

Awarded date

15 January 2021

Contract start date

12 February 2021

Contract end date

11 February 2025

Total value of contract

£502,000

This contract was awarded to 2 suppliers.

VH Bio Ltd

Address

Unit 11b Station Approach, Team Valley Trading Estate, Gateshead, NE11 0ZF

Reference

No reference - other

Supplier is SME?

No

Supplier is VCSE?

No

Alpha Biotech Ltd

Address

Ythan Lodge, Drumore Road, Killearn, G63 9NX

Reference

No reference - other

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Address

500 North Bristol Park
Bristol
BS43 7QH
England

Email

marta.drozdzowska@nhsbt.nhs.uk